Mostrar el registro sencillo del ítem

dc.contributor.authorVilanova-Pereira, M.*
dc.contributor.authorJácome, C.*
dc.contributor.authorRial Prado, Manuel Jorge *
dc.contributor.authorBarral-Fernández, M.*
dc.contributor.authorBlanco Aparicio, Marina *
dc.contributor.authorGarcía-Boente, L.F.*
dc.contributor.authorLista-Paz, A.*
dc.date.accessioned2025-09-09T10:24:41Z
dc.date.available2025-09-09T10:24:41Z
dc.date.issued2023
dc.identifier.citationVilanova-Pereira M, Jácome C, Prado MJR, Barral-Fernández M, Aparicio MB, García-Boente LF, et al. Effectiveness of nordic walking in patients with asthma: A study protocol of a randomized controlled trial. PLoS ONE. 2023;18(3 March).
dc.identifier.issn1932-6203
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/64204548e1b5e93884fa78e8
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21407
dc.description.abstractBackground Patients with asthma often consider their symptomatology a barrier to exercise, leading to a reduced physical activity level. This study aims to determine whether the effect of a Nordic walking (NW) training program plus education and usual care is superior to educational and usual care only, in terms of exercise tolerance and other health-related outcomes in patients with asthma. The second aim is to explore the patients' experience with the NW program. Methods A randomized controlled trial will be conducted with 114 adults with asthma recruited in sanitary area of A Coruña, Spain. Participants will be randomized to NW or control groups in blocks of six and in the same proportion in each group. Participants in the NW group will enrol in supervised sessions during eight weeks, three times/week. All participants will receive three educational sessions on asthma self-management plus usual care (S1 Appendix). Outcomes such as exercise tolerance (primary outcome), physical activity level, asthma-related symptoms and asthma control, dyspnea, lung function, handgrip strength, health related quality of life, quality of sleep, treatment adherence and healthcare resources use will be measured pre and postintervention, and at three and six months of follow-up. Participants in the NW group will additionally participate in focus groups. Discussion This is the first study analysing the effect of NW in patients with asthma. NW combined with education and usual care is expected to improve exercise tolerance, but also asthma-related outcomes. If this hypothesis is confirmed, a new community-based therapeutic approach will be available for patients with asthma.
dc.languageeng
dc.rightsAttribution 4.0 International (CC BY 4.0)*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAdult *
dc.subject.meshHumans *
dc.subject.meshQuality of Life *
dc.subject.meshNordic Walking *
dc.subject.meshHand Strength *
dc.subject.meshAsthma *
dc.subject.meshExercise *
dc.subject.meshWalking *
dc.subject.meshRandomized Controlled Trials as Topic *
dc.titleEffectiveness of nordic walking in patients with asthma: A study protocol of a randomized controlled trial
dc.typeArtigo
dc.authorsophosVilanova-Pereira, M.; Jácome, C.; Prado, M.J.R.; Barral-Fernández, M.; Aparicio, M.B.; García-Boente, L.F.; Lista-Paz, A.
dc.identifier.doi10.1371/journal.pone.0281007
dc.identifier.sophos64204548e1b5e93884fa78e8
dc.issue.number3 March
dc.journal.titlePLoS ONE*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Alergoloxía
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Complexo Hospitalario Universitario A Coruña::Neumoloxía
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0281007
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.subject.keywordAS A Coruña
dc.subject.keywordCHUAC
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number18


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution 4.0 International (CC BY 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International (CC BY 4.0)